No Appeal of LDT/FDA Lawsuit

No Appeal of LDT/FDA Lawsuit

The FDA had until May 30 to appeal U.S. District Court Judge Sean D. Jordan's decision to vacate the agency's Final Rule seeking to regulate laboratory developed tests (LDTs). The federal government declined to appeal the judge's decision meaning the Texas District Court's decision to vacate, in its entirety, the FDA's attempt to regulate LDTs as medical devices stands.

Read ACLA’s full lawsuit.

Read the Final Judgment.

 

CAP Comments on CMS Antifraud Efforts, Urges Reevaluation of MolDX Program

CAP Comments on CMS Antifraud Efforts, Urges Reevaluation of MolDX Program

The College of American Pathologists (CAP) submitted comments in response to a request for information on the Centers for Medicare & Medicaid...

Read More
TELCOR Acquires Sample Healthcare to Lead AI-Driven Transformation of Revenue Cycle Operations

TELCOR Acquires Sample Healthcare to Lead AI-Driven Transformation of Revenue Cycle Operations

Lincoln, NE — April 1, 2026 — TELCOR Inc, a leading provider of healthcare technology solutions for laboratories and healthcare facilities, today...

Read More
CMS Adopts Final Rule Phasing Out Fax and Mail for Health Care Claims Attachments

CMS Adopts Final Rule Phasing Out Fax and Mail for Health Care Claims Attachments

The Centers for Medicare & Medicaid Services (CMS) issued a final rule on national standards for electronic claims attachments and signatures,...

Read More